Inventor · disambiguated record
Richard P. Blye
Also filed as: BLYE RICHARD · BLYE RICHARD P
13 granted patents·4 pending applications·197 citations·filing 1979–2013
91Inventor score
Top patents by PatentIndex Score
17 records- 0193US6900193B1Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agentsUS HEALTH·Filed 2000·Granted May 31, 2005·56 cites·56 claims
- 0291US7196074B2Methods of making, using and pharmaceutical formulations comprising 7α, 11β-dimethyl-17β-hydroxyestra-4, 14-dien-3-one and 17 esters thereofUS HEALTH·Filed 2002·Granted Mar 27, 2007·55 cites·96 claims
- 0389US7087591B221-substituted progesterone derivatives as new antiprogestational agentsUS HEALTH·Filed 2005·Granted Aug 8, 2006·13 cites·18 claims
- 0480US6861415B221-substituted progesterone derivatives as new antiprogestational agentsUS HEALTH·Filed 1997·Granted Mar 1, 2005·37 cites·36 claims
- 0573US4252800A7α-methylnorethindrone enanthate and its use in long term suppression of fertility in female mammalsUSA·Filed 1979·Granted Feb 24, 1981·8 cites·7 claims
- 0671US7820642B2Nandrolone 17β-carbonatesUS HEALTH·Filed 2006·Granted Oct 26, 2010·1 cites·62 claims
- 0770US8569276B2Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agentsKIM HYUN K·Filed 2005·Granted Oct 29, 2013·2 cites·52 claims
- 0869US8003629B221-substituted progesterone derivatives as new antiprogestational agentsUS HEALTH·Filed 2009·Granted Aug 23, 2011·0 cites·34 claims
- 0963US5554603AOrally active derivatives of 1,3,5(10)-estratrieneUS HEALTH·Filed 1993·Granted Sep 10, 1996·19 cites·9 claims
- 1063US2009023695A1METHOD OF MAKING AND USING 7alpha,11beta-DIMETHYL-17beta-HYDROXYESTR-4-EN-3-ONE 17-UNDECANOATEUS HEALTH·Filed 2008·Application pending·0 cites
- 1161US2014107089A1Structural modification of 19-norprogesterone i: 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agentsUS HEALTH·Filed 2013·Application pending·0 cites
- 1260US7759330B221-substituted progesterone derivatives as new antiprogestational agentsUS HEALTH·Filed 2006·Granted Jul 20, 2010·0 cites·38 claims
- 1355US2005130944A1Method of making and using 7alpha,11beta-dimethyl-17beta-hydroxyestr-4-en-3-one 17-undecanoateUS GOV HEALTH & HUMAN SERV·Filed 2005·Application pending·0 cites
- 1452US2003069215A1Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydroxyestr-4-en-3-one 17-undecanoateUS GOV HEALTH & HUMAN SERV·Filed 2002·Application pending·0 cites
- 1550US10351587B2Method of making and using 7α, 11β-dimethyl-17β-hydroxyestr-4-en-3-one 17-undecanoateBLYE RICHARD P·Filed 2011·Granted Jul 16, 2019·0 cites·22 claims
- 1637US4308265A7α-Methylnorethindrone enanthate and its use in long term suppression of fertility in female mammalsUSA·Filed 1980·Granted Dec 29, 1981·2 cites·4 claims
- 1732US4948790ALong-acting androgenic compounds and pharmaceutical compositions thereofARCHER SYDNEY·Filed 1987·Granted Aug 14, 1990·4 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Richard P. Blye files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →